Catalys Pacific
Finance · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Pine St Ste 1250, San Francisco, Cal...Phone Number
+81 368958877Website
www.catalyspacific.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Catalys Pacific
Catalys Pacific is focused on transforming life sciences innovation by creating and investing in global biotech companies. The company specializes in developing targeted therapies for patients with conditions such as hypertension and chronic kidney disease, leveraging its extensive network and local presence in Japan and the United States. Their strategy emphasizes early-stage investment opportunities and transpacific partnerships to maximize therapeutic impact and generate attractive returns for investors. Catalys Pacific aims to improve patient lives through bespoke innovations in the healthcare sector.Explore more
Catalys Pacific Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Catalys Pacific your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Catalys Pacific has new funding data
Earning: See what the market has to say on Catalys Pacific recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Catalys Pacific
Check out if Catalys Pacific is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Catalys Pacific had a recent Job posting/layoffs
Catalys Pacific, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Catalys Pacific has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Catalys Pacific launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Catalys Pacific
Find more new buyers
Compare Similar Companies to Catalys Pacific
Compare insights from companies similar to Catalys Pacific, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Catalys Pacific is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Catalys Pacific is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Catalys Pacific.
Catalys Pacific Tech Stack
A closer look at the technologies used by Catalys Pacific
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Catalys Pacific News & Media
Renalys Pharma Closes ¥6.0Bn Series A Financing to Advance Kidney Disease Treatments Across Asia
Financing Round Co-led by Catalys Pacific and SR One, Investment to Drive the Development of Sparsentan for IgA Nephropathy in Japan and Other Asian Countries TOKYO, July 17, 2024 /PRNewswire/ -- Renalys Pharma, Inc., a late-stage clinical biopharmaceutical company has completed a ¥6.0Bn...Renalys Pharma Is Launched To Bring New Innovative Medicines To Patients In Japan and Other Countries In Asia
Co-founded by Catalys Pacific and SR One, Renalys Pharma is an exemplification of how game-changing life-science biopharma can be created through investor partnerships TOKYO, Jan. 25, 2024 /PRNewswire/ -- Catalys Pacific, a transpacific life science investment firm, and SR One, a...Pathalys Pharma Raises $150M in Secured Product Financing and Equity
Pathalys Pharma, a Raleigh, NC-based private, late-stage biopharma company, raised $150M in Secured Product financing and equity funding. Abingworth led both financings and was joined by Carlyle and OrbiMed, along with Pathalys’ founding investors Catalys Pacific and DaVita Venture Group. The company intends to use the funds to support the two phase 3 clinical trials, […] The post Pathalys Pharma Raises $150M in Secured Product Financing and Equity appeared first on FinSMEs.Catalys Pacific Launches Kirilys Therapeutics as a Multi-asset Precision Oncology Company
SAN FRANCISCO--(BUSINESS WIRE)--Catalys Pacific launches Kirilys Therapeutics as a multi-asset precision oncology company with seed financing led by Lightspeed Ventures.
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Catalys Pacific
Sign Up For FreeTo access detailed company insights
Catalys Pacific is focused on transforming life sciences innovation by creating and investing in global biotech companies. The company specializes in developing targeted therapies for patients with conditions such as hypertension and chronic kidney disease, leveraging its extensive network and local presence in Japan and the United States. Their st... Read More
